Eukroma Kj Cream

📦 Każde zamówienie jest objęte naszą Reshipment Assurance Policy — jeśli Twoja przesyłka nie dotrze w ciągu 20 dni roboczych, wysyłamy ją ponownie.

Dlaczego warto zamawiać z MedsBase

Nasze leki generyczne pochodzą od producentów posiadających certyfikat WHO-GMP i są wysyłane na cały świat w dyskretnym, zwykłym opakowaniu — bez nazwy leku na zewnątrz przesyłki. Płatności kartami są kierowane przez regulowanego procesora (opis wyciągu zawiera nazwę regulowanego procesora płatności — nigdy “MedsBase” ani żadnej nazwy leku). Akceptujemy również kryptowaluty i przelewy bankowe SEPA. Każde zamówienie jest objęte naszą Reshipment Assurance Policy.

What Is Eukroma-KJ Cream?

Eukroma-KJ Cream is a topical depigmenting cream from Yash Pharma that pairs hydroquinone 4% — the gold-standard topical depigmenting agent — with kojic acid 2%, a tyrosinase inhibitor derived from Aspergillus oryzae fermentation. The “-KJ” suffix in the brand name denotes the Kojic acid + hydroquinone (somet­imes written HJ) formulation; this is not the multi-ingredient “Kligman triple” (which additionally contains tretinoin and a topical corticosteroid).

The hydroquinone + kojic acid combination is positioned between single-ingredient hydroquinone (gentler, slower) and the Kligman triple (faster, more side effects). Kojic acid potentiates hydroquinone's tyrosinase inhibition without the steroid-atrophy and rebound-dermatitis risks of a corticosteroid-containing cream, so the safe cycle length is 4–6 months (comparable to single-ingredient hydroquinone) rather than the 8-week limit of the Kligman triple. Eukroma-KJ Cream is a prescription product intended for cyclical, medically-supervised use — not for open-ended cosmetic skin-lightening.

How Does Eukroma-KJ Cream Work?

Both actives target the rate-limiting enzyme in melanin production, tyrosinase, but at different points on the enzyme — which is why the combination is stronger than either ingredient alone:

• Hydroquinone 4% competes with the enzyme's natural substrate (tyrosine / DOPA) at the active site, blocking melanin synthesis at its rate-limiting step. At this concentration it also produces selective melanocyte cytotoxicity, reducing overall melanocyte activity in the treated patch.
• Kojic acid 2% chelates the copper ion that sits at the heart of the tyrosinase active site. Without its copper cofactor, tyrosinase cannot catalyse melanin synthesis at all. Kojic acid also scavenges UV-induced free radicals that trigger melanocyte activation.

The visible result is lightening at 4–8 weeks, peak benefit at 3–4 months, and continued maintenance thereafter provided the cycling protocol is respected. The effect is entirely UV-dependent — without rigorous daily SPF 50+, every gain reverses within days of unprotected sun, and continuing to apply the cream on already-reactivated skin paradoxically increases the risk of ochronosis.

— wzmacnia normalną odpowiedź fizjologiczną, a nie wywołuje ją sztucznie.

• Melasma (chloasma) — symmetric brown patches on cheeks, forehead, upper lip, often hormonally driven (pregnancy, COCP use, peri-menopause)
• Post-inflammatory hyperpigmentation (PIH) after acne, eczema, burns or laser; particularly useful on Fitzpatrick III–VI skin where PIH is stubborn
• Solar lentigines (sun spots, age spots) on the face and dorsum of hands
• Periorbital / perioral hyperpigmentation (used sparingly, keeping well clear of the eyelid margin and lip vermilion)
• Maintenance after a Kligman-triple cycle — when stepping down from the 8-week triple combo, Eukroma-KJ Cream is a reasonable maintenance product for a further 4–6 months

Eukroma-KJ Cream is not appropriate for: deep dermal-pigment melasma (responds to laser or chemical peels rather than topicals), broken or eczematous skin, daily long-term cosmetic skin-lightening (the population at highest risk of ochronosis), freckles (ephelides — UV-driven and tend to recur), or conditions requiring a prescription corticosteroid (for which a Kligman-triple cream would be the better choice).

Eukroma-KJ Cream Dosage and How to Apply

Eukroma-KJ Cream is supplied as a cream in 1, 3 or 6 tube packs containing 4% hydroquinone and 2% kojic acid. Apply to the affected dark patches only, not to the entire face or body.

How to Apply Eukroma-KJ Cream Properly

1. Delikatnie umyj with a mild, non-foaming cleanser and pat dry. Wait 20–30 minutes for the skin to fully dry — applying hydroquinone to damp skin increases stinging and absorption unpredictably.
2. Patch test first. Apply a pea-sized amount to the inner forearm once daily for 48–72 hours before facial use. Kojic acid causes allergic contact dermatitis in 5–10% of users — more commonly than hydroquinone alone — and a positive patch test means you cannot use this cream.
3. Apply a thin film only to the dark patches, not to the surrounding healthy skin. Use a cotton swab for precision on small patches (e.g. periorbital or perioral areas).
4. Unikać the eyes, eyelids, mouth corners, nostrils, lips, mucous membranes, and the anterior neck.
5. Stosuj raz na noc is the standard regimen. Some dermatologists increase to twice daily (morning + evening) after 2–3 weeks if well tolerated, but this increases the risk of ochronosis and is not recommended for first-time users.
6. Maximum continuous course: 4–6 months. After this, take a 2–3 month break before any further course. Do not exceed 8 months of total hydroquinone use in any rolling 12-month period.
7. Daily broad-spectrum SPF 50+ every morning is non-negotiable — not just during treatment but indefinitely after. Mineral (zinc oxide or titanium dioxide) or hybrid sunscreen is preferred for melasma. Reapply every 2–3 hours outdoors. Use a wide-brimmed hat and avoid tanning beds completely.
8. Stop immediately if you notice blue-black or slate-grey discolouration of the treated patches, persistent burning, blistering, or rebound darkening. Do not continue through these warning signs.

Side Effects of Eukroma-KJ Cream

Common (mild; settles in the first 2–3 weeks):

• Mild dryness or peeling on the treated patch
• Stinging or burning on application (worst in weeks 1–2)
• Mild redness around the treated area
• Increased sun sensitivity on the treated skin

Rzadsze:

• Allergic contact dermatitis — 5–10% with this combination (kojic acid is a more common sensitiser than hydroquinone alone)
• Halo effect — lightening of the healthy skin immediately surrounding the treated patch, producing a visible ring. Mitigate by keeping application strictly on the patch itself.
• Temporary hyperpigmentation rebound when the cream is stopped abruptly without a maintenance product or SPF

Rare but stop and seek dermatology review:

• Exogenous ochronosis — paradoxical blue-black or slate-grey pigmentation; develops with continuous use beyond 6 months, particularly on Fitzpatrick V–VI skin at hydroquinone concentrations of 4% and above. Can be permanent. Stop the cream at the first suspicion.
• Severe contact dermatitis with vesicles, weeping or persistent burning
• Periorbital depigmentation (from creep onto the eyelid area)

Ostrzeżenia i środki ostrożności

• Ciąża i karmienie piersią: contraindicated. Hydroquinone is FDA Pregnancy Category C with up to 35% systemic absorption from facial application. For pregnancy-related melasma, switch to azelaic acid 15–20% (Pregnancy Category B) with strict SPF 50+.
• Ekspozycja na słońce: daily broad-spectrum SPF 50+ is mandatory. Without it, the depigmenting effect reverses within days and ochronosis risk rises sharply.
• Cycling protocol: never use continuously beyond 6 months. Take a 2–3 month break between courses. Do not exceed 8 months of hydroquinone use in any 12-month period.
• FDA Action 2020: all OTC hydroquinone products were removed from the US market in September 2020. Hydroquinone is now restricted to specialist supervision in the US, EU, Japan and most of Asia.
• Kojic acid sensitivity: patients with a prior allergic contact dermatitis to kojic acid—containing cosmetic products should not use Eukroma-KJ Cream. Choose a single-ingredient hydroquinone cream instead.
• Fitzpatrick V–VI skin: higher ochronosis risk. Consider starting at a lower hydroquinone concentration (2%) for 2–3 months before stepping up to 4%.
• Do not apply on broken skin, active eczema, severe sunburn, or open wounds.
• Waxing, threading, laser hair removal, dermabrasion, microneedling, chemical peels: stop Eukroma-KJ Cream for 7–10 days before any of these procedures, and do not restart until the skin has fully re-epithelialised.
• Dzieci poniżej 12 roku życia: not for paediatric use.

Contraindications — Who Should NOT Use Eukroma-KJ Cream

• Known hypersensitivity to hydroquinone, kojic acid or any component of the formulation
• Ciąża, planowanie ciąży lub karmienie piersią
• Active eczema, severe rosacea, weeping dermatitis, or open wounds on the area to be treated
• Established exogenous ochronosis (hydroquinone-induced blue-black pigmentation)
• Prior documented allergic contact dermatitis to a kojic acid—containing product
• Dzieci poniżej 12 roku życia
• Patients unwilling to commit to daily SPF 50+ and the cycling protocol — the risk/benefit does not justify use

Interakcje leków i produktów do pielęgnacji skóry

Instrukcja przechowywania

• Przechowywać w temperaturze pokojowej, 15–25°C. Keep the tube tightly closed and out of direct sunlight.
• Hydroquinone oxidises (turns brown or grey) when exposed to air and light and loses potency rapidly once discoloured. If the cream has darkened, discard the tube.
• Discard 6 months after first opening, even if product remains.
• Przechowywać w miejscu niedostępnym dla dzieci.

Powiązane alternatywy w MedsBase

Other depigmenting and acne products stocked on MedsBase:

• Melrio Cream (hydroquinone + tretinoin + fluocinolone)
• Melacare Forte Cream (hydroquinone + tretinoin + mometasone)
• Kojiglo Forte Cream (hydroquinone + tretinoin + mometasone)
• Epilite Liquid (hydroquinone 2%)
• Retino-A Cream (tretinoin 0.025% / 0.05%)
• Tretiheal Cream (tretinoin 0.025% / 0.05% / 0.1%)
• Isotroin (oral isotretinoin 5 / 10 / 20 / 30 mg)

Przydatne lektury: Krem z tretynoiną vs żel · Tretinoin vs retinol · Wszystko, co chcesz wiedzieć o trądziku.

Najczęściej zadawane pytania

When will I see results from Eukroma-KJ Cream?

Visible lightening begins at 4–8 tygodniach; peak benefit at 3–4 months. If you are not seeing any lightening at 8 weeks you are most likely either missing daily SPF (the single biggest reversible failure cause), applying to damp or recently washed skin, or have a deep dermal-pigment melasma that needs a laser or chemical peel rather than a topical.

Why combine hydroquinone with kojic acid?

The two actives inhibit tyrosinase (the rate-limiting enzyme in melanin synthesis) at different points on the enzyme. Hydroquinone competes with tyrosinase's natural substrate at the active site; kojic acid chelates the copper cofactor the enzyme needs to function. Hitting both points simultaneously is stronger than either alone, and kojic acid also scavenges UV-induced free radicals that trigger melanocyte activation. The trade-off is a slightly higher rate of allergic contact dermatitis from kojic acid (5–10% vs 3–5% for hydroquinone alone).

How is Eukroma-KJ Cream different from a Kligman-triple cream (Melrio, Melacare, Kojiglo)?

A Kligman-triple cream adds tretinoin (a retinoid) and a topical corticosteroid to hydroquinone. It is faster and more potent than Eukroma-KJ Cream, but the steroid limits safe use to 8-week cycles (longer use causes skin atrophy, telangiectasia and steroid-induced rosacea). Eukroma-KJ Cream has no steroid and no retinoid, so it can be cycled for 4–6 months at a time. Many dermatologists prescribe a Kligman triple for an aggressive 8-week induction phase, then step down to a hydroquinone + kojic acid cream like Eukroma-KJ Cream for maintenance.

Can I use Eukroma-KJ Cream during pregnancy or breastfeeding?

Nie. Hydroquinone is FDA Pregnancy Category C with up to 35% systemic absorption from facial application. For pregnancy-related melasma, switch to azelaic acid 15–20% (Pregnancy Category B) with rigorous SPF 50+, which is safe for both pregnancy and breastfeeding.

What is exogenous ochronosis and how do I avoid it?

Exogenous ochronosis is a blue-black or slate-grey paradoxical pigmentation caused by continuous hydroquinone use beyond 6 months, especially at 4% concentration and on Fitzpatrick V–VI skin. It can be permanent. Prevention: (1) strict 4–6 month maximum continuous course, (2) 2–3 month break between cycles, (3) daily SPF 50+ without exception, (4) application only to the affected patch — never to healthy surrounding skin — and (5) stop immediately if treated patches are darkening rather than lightening.

Why do I need SPF 50+ every day?

UV exposure reactivates melanocytes and reverses every gain you have made from Eukroma-KJ Cream within days. Incidental sun exposure (driving, walking to the shop, sitting near a window) is enough to undo weeks of cream use. Broad-spectrum SPF 50+ is more important than the cream itself for long-term hyperpigmentation control. Mineral or hybrid sunscreens (zinc oxide and/or titanium dioxide) work better than chemical filters for melasma because they block visible-light pigment triggers as well as UV.

Can I layer Eukroma-KJ Cream with tretinoin at night?

Yes, but not simultaneously on the same skin. Stacking the two immediately together increases stinging and ochronosis risk. The practical options are: (a) alternate nights — Eukroma-KJ Cream on night 1, tretinoin on night 2; or (b) layer with a 30-minute wait between applications so the first has fully absorbed. Do not mix the two products in the palm before applying.

What does the “halo effect” mean and how do I avoid it?

The halo effect is unwanted lightening of the healthy skin immediately around a treated dark patch, producing a visible paler ring. It is a direct consequence of applying Eukroma-KJ Cream beyond the edge of the dark patch onto surrounding normal-coloured skin. Prevent it by keeping application strictly on the patch itself — use a cotton swab for small patches, apply the cream with a clean fingertip for larger patches, and never “feather out” into the margin.

Can I use Eukroma-KJ Cream on my neck, chest or hands?

Yes. Off-face use is appropriate for solar lentigines on the dorsum of the hands, “sun necklace” pigmentation on the anterior chest, and post-inflammatory marks on limbs. The same cycling protocol (4–6 month maximum continuous course) applies, and daily SPF 50+ on the treated areas is mandatory. Kligman-triple combinations are otrzymuje, przechowuje, nie ma dostępu ani wglądu w dane osobowe przekazywane przez Ciebie dostawcy płatności. Proces weryfikacji odbywa się w całości na platformie dostawcy i podlega jego własnej polityce prywatności oraz standardom bezpieczeństwa. recommended for off-face use because the steroid causes atrophy with prolonged body-area exposure — Eukroma-KJ Cream (no steroid) is the safer off-face choice.

Is hydroquinone safe? I have seen claims it causes cancer.

The IARC classifies hydroquinone as Group 3 — not classifiable as to carcinogenicity in humans. The cancer signal in animal studies has not translated to topical human exposure in decades of dermatology use at 2–4% concentration. The real safety concern is exogenous ochronosis (a pigmentation side effect), not cancer, and it is fully preventable by sticking to the cycling protocol and daily SPF 50+.

More options in Beauty & Skin Care

Ranking według liczby ostatnich zamówień MedsBase — co wybierają inni klienci w tej kategorii.

Krem Tretiheal

US$7.00 – US$54.00Zakres cen: US$7.00 do US$54.00

Krem Melalite Forte

US$5.00 – US$27.00Zakres cen: US$5.00 do US$27.00

Krem Retino A

US$8.00 – US$42.00Zakres cen: US$8.00 do US$42.00

Żel Kojiglo

US$18.00 – US$87.00Zakres cen: US$18.00 do US$87.00